Endocyte Raises $26 Million
Endocyte Inc., a West Lafayette, Ind.-based developer of receptor-targeted therapeutics for the treatment of cancer and autoimmune diseases, has raised $26 million in new Series C funding. Clarian Health Ventures was joined by return backersSanderling Ventures, Burrill & Co., American Bailey Ventures, Blue Chip Venture Co., and Triathlon Medical Ventures. Endocyte has raised around $61 million in total VC funding since 2001.
18 October 2009•3 mins read
